ITGAX and neoplasm: In stark contrast, CD45+CD11b+CD11c- cells from the bone marrow of tumor-bearing mice exhibited low co-expression of VISTA and MHCII, indicating that upregulation of these two markers was tumor-specific (Figure S2b).